Biocon Limited is India’s premier Biopharma enterprise focused on innovation to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe.
Established in 1978 by Ms. Kiran Mazumdar-Shaw, Biocon is committed to reduce therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases to provide access to affordable treatment to patients across the global.
Biocon’s key innovations include world’s first Pichia based recombinant human Insulin, INSUGEN®, insulin analog Glargine, BASALOG® and India’s first indigenously produced monoclonal antibody BioMAb-EGFR® , for head & neck cancer. INSUPen® is a next generation affordable insulin delivery device introduced in India.
Biocon is also the largest Indian Insulin’s Company and it provides insulin’s in over 30 countries. With a risk balanced business model comprising small molecules, novel molecules, biosimilars, branded formulations and research services, Biocon has evolved into an emerging global enterprise serving its partners and customers in over 70 countries. With an existing number of 7,800 employees, Biocon has received global recognition from the ‘Science’ Magazine as one of the top 20 global employers in Biopharma.
Biocon Sdn Bhd:
Biocon, India’s leading and Asia’s premier biopharmaceutical enterprise has set up its first state-of-art overseas bio-pharma manufacturing and research facility located within a 40 acre compound, at Bio-XCell, Johor in Malaysia.
With an investment of over USD 200 million, this is the largest foreign investment in the Biopharma sector in Malaysia. The facility once fully operational in 2016, will be the largest integrated insulin production plant in Asia. Biocon’s Malaysia facility will further augment its capabilities to cater to the global needs of diabetic patients for affordable insulin and insulin analogs.
Biocon Malaysia offers an excellent career opportunity for biotech professionals.
No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian SILC, Johor, Malaysia, 79200 Nusajaya
Company Registration No: